1. OP0085 Therapeutic Inhibition of Anti-Apoptotic BCL-2 Family Proteins in a Murine Model of Lupus Nephritis. (23rd January 2014) Authors: Wang, L. C.; Perper, S.; Perron, D.; Tarcsa, E.; Bardwell, P.; Mozaffarian, N.; Souers, A.; Elmore, S.; Ghayur, T.; Olson, L. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0136 BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation. (9th June 2015) Authors: Wang, L.C.; Ko, K.; Yanez, D.; Kaverina, N.; Liarski, V.M.; Peng, Y.; Lan, L.; Perper, S.; Schwartz, A.; O'Connor, L.; Souers, A.; Elmore, S.; Olson, L.; Giger, M.L.; Clark, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0382 Venetoclax (ABT-199), A Potent and Selective BCL-2 Inhibitor, Prevents Nephritis in Lupus Prone NZB/W F1 Mice by Depleting Selective Lymphocyte Populations While Sparing Platelets. (9th June 2015) Authors: Wang, L.C.; Perper, S.; Schwartz, A.; Goess, C.; O'Connor, L.; Hartman, D.; Graff, C.; Souers, A.; Leverson, J.; Elmore, S.; Olson, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗